EDGAR Filing Documents for 0001558370-23-005292

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-23-005292

Filing Date

2023-03-31

Accepted

2023-03-31 16:13:06

Documents

101

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	nrxp-20221231x10k.htm iXBRL	10-K	3122288
2	EX-10.53	nrxp-20221231xex10d53.htm	EX-10.53	44062
3	EX-23.1	nrxp-20221231xex23d1.htm	EX-23.1	2260
4	EX-31.1	nrxp-20221231xex31d1.htm	EX-31.1	12338
5	EX-31.2	nrxp-20221231xex31d2.htm	EX-31.2	12623
6	EX-32.1	nrxp-20221231xex32d1.htm	EX-32.1	6116
7	EX-32.2	nrxp-20221231xex32d2.htm	EX-32.2	6087
8	GRAPHIC	nrxp-20221231x10k001.jpg	GRAPHIC	33747
9	GRAPHIC	nrxp-20221231x10k002.jpg	GRAPHIC	15668
10	GRAPHIC	nrxp-20221231x10k003.jpg	GRAPHIC	19333
11	GRAPHIC	nrxp-20221231x10k004.jpg	GRAPHIC	17245
12	GRAPHIC	nrxp-20221231x10k005.jpg	GRAPHIC	28761
13	GRAPHIC	nrxp-20221231x10k006.jpg	GRAPHIC	42403
14	GRAPHIC	nrxp-20221231x10k007.jpg	GRAPHIC	11835
15	GRAPHIC	nrxp-20221231x10k008.jpg	GRAPHIC	12511
16	GRAPHIC	nrxp-20221231x10k009.jpg	GRAPHIC	26958
17	GRAPHIC	nrxp-20221231x10k010.jpg	GRAPHIC	15665
18	GRAPHIC	nrxp-20221231x10k011.jpg	GRAPHIC	44889
	Complete submission text file	0001558370-23-005292.txt		11334872

Data Files

Seq	Description	Document	Type	Size
19	EX-101.SCH	nrxp-20221231.xsd	EX-101.SCH	87902
20	EX-101.CAL	nrxp-20221231_cal.xml	EX-101.CAL	61621
21	EX-101.DEF	nrxp-20221231_def.xml	EX-101.DEF	414190
22	EX-101.LAB	nrxp-20221231_lab.xml	EX-101.LAB	557423
23	EX-101.PRE	nrxp-20221231_pre.xml	EX-101.PRE	610750
95	EXTRACTED XBRL INSTANCE DOCUMENT	nrxp-20221231x10k_htm.xml	XML	1406460

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801

Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134

NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)